Two Years of the COVID-19 Pandemic: What Lessons Have We Learned?

Two years ago, the World Health Organization declared a global pandemic after an outbreak of a novel coronavirus. Since then, unprecedented challenges have shaped a "new normal." As of early March 2022, more than 6 million lives have been lost globally to COVID-19.

Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.

Objective: To compile and synthesize the available literature describing medical cannabis use across various disease states.

Data Sources: PubMed, EBSCO, and Google Scholar searches were conducted using MeSH and/or keywords.

Study Selection And Data Extraction: Studies were included if they described the use of cannabis-based products and medications in the treatment of a predefined list of disease states in humans and were published in English.

Patient utilization of prescription opioids after discharge from the emergency department.

Background: Emergency department (ED) visits associated with prescription opioids have increased in the last ten years. This study describes the opioid utilization of patients discharged from the ED with an opioid prescription for pain, 14 to 21 days post discharge.

Methods: This is a prospective, single-centered, survey-based observational descriptive study conducted from December 2017 to February 2018 in the ED at a tertiary level 1 trauma center.

Seizure Prophylaxis in Patients with Traumatic Brain Injury: A Single-Center Study.

The use of prophylactic anticonvulsants to prevent early post-traumatic seizures (PTSs) is recommended but inconsistently employed in patients with traumatic brain injury (TBI). The authors evaluated outcomes associated with prophylaxis administration in patients with TBI at a Level 1 trauma center. All patients admitted with TBI from October 2007 through May 2012 were included.